EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Approach to Interrogating Whole Genome Sequencing Data to Optimise Clinical Utility

Sarah Sonner, Caoimhe McKenna, Shirley Heggarty, Cassie Hamill, Cheryl Flanagan, Shane McKee iD, Katie Kerr iD, Rasha Alhazzaa iD, Amy Jayne McKnight iD, Fionnuala Mone iD

Molecular Genetics & Genomic Medicine · 2026-06 · 14 (6)

DOI: 10.1002/mgg3.70248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 11.06.2026. Verfasst von Sarah Sonner und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Public Health, Queen's University Belfast, Belfast, UK. Hauptthemen laut MEDLINE: Whole Genome Sequencing, Genetic Testing, Rare Diseases, Genomics. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department for the Economy, Medical Research Council, Northern Ireland Executive.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the performance of the genomic analytics applied to the Northern Ireland cohort recruited to the 100,000 Genomes Project, focusing on diagnostic yields in first‐line analysis and revisiting inconclusive cases with rare diseases.

Methods

Whole genome sequencing (WGS) and initial data processing were performed centrally by Genomics England (GEL), consistent with a national protocol. A novel internal approach to variant selection and interpretation was designed using a two‐pronged pathway; with initial prioritisation using GEL virtual panels and subsequent Exomiser‐mediated reanalysis of remaining undiagnosed cases. Retrospective collection of genomic records was completed for service evaluation.

Results

Of 440 patients recruited 20.2% ( n = 89/440) received a monogenic diagnosis; 69.7% ( n = 62/89) via the initial interpretation pathway (analysed between 2019 and 2021) and 30.3% ( n = 27/89) via the secondary pathway (analysed between 2019 and 2025). The majority of variants missed by the initial analysis were because the diagnostic gene was not included as a target on the applied panel(s) at the time of analysis. The median turnaround time for the initial approach was 644.5 days (range: 315–1342) and for the secondary approach was 1766.5 days (range: 862–2311). The secondary approach was found to be more effective in prioritising pathogenic variants; 69.7% ( n = 62/89) versus 89.9% ( n = 80/89) p = 0.0008.

Conclusion

Pre‐classification variant selection and reanalysis of undiagnosed cases are critical to optimise quality improvement in the clinical delivery of WGS. Variant selection via virtual panels can expedite interpretation but may miss clinically relevant findings, leaving cases undiagnosed. Revisiting these cases gave an additional ~6% yield. For efficient variant selection in both initial and follow‐up analysis, a multi‐disciplinary approach is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Whole Genome SequencingGenetic TestingRare DiseasesGenomicsHumansNorthern Ireland

Autor:innen und Institutionen

  • Centre for Public Health, Queen's University Belfast, Belfast, UK.
  • Northern Ireland Genomic Medicine Centre, Belfast Health and Social Care Trust, Belfast, UK.
  • Regional Molecular Diagnostics Service (Germline), Belfast Health and Social Care Trust, Belfast, UK.
  • Health Informatics Department, Saudi Electronic University, College of Health Sciences, Dammam, Saudi Arabia.
  • Centre for Fetal Medicine, Belfast Health and Social Care Trust, Belfast, UK.

ORCID-Profile: Shane McKee, Katie Kerr, Rasha Alhazzaa, Amy Jayne McKnight, Fionnuala Mone

Förderung

  • Department for the Economy
  • Medical Research Council
  • Northern Ireland Executive

Zitieren

APA

Sonner, S., McKenna, C., Heggarty, S., Hamill, C., Flanagan, C., McKee, S., Kerr, K., Alhazzaa, R., McKnight, A. J., & Mone, F. (2026). A Novel Approach to Interrogating Whole Genome Sequencing Data to Optimise Clinical Utility. Molecular Genetics & Genomic Medicine, 14(6). https://doi.org/10.1002/mgg3.70248

Vancouver

Sonner S, McKenna C, Heggarty S, Hamill C, Flanagan C, McKee S, et al. A Novel Approach to Interrogating Whole Genome Sequencing Data to Optimise Clinical Utility. Molecular Genetics & Genomic Medicine. 2026;14(6). doi:10.1002/mgg3.70248

BibTeX
@article{Sonner2026,
  author = {Sonner, Sarah and McKenna, Caoimhe and Heggarty, Shirley and Hamill, Cassie and Flanagan, Cheryl and McKee, Shane and Kerr, Katie and Alhazzaa, Rasha and McKnight, Amy Jayne and Mone, Fionnuala},
  title = {A Novel Approach to Interrogating Whole Genome Sequencing Data to Optimise Clinical Utility},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2026},
  volume = {14},
  number = {6},
  doi = {10.1002/mgg3.70248}
}
Kostenlos starten →